Epidemiology; diagnosis, and treatment of male hypogonadotropic hypogonadism

Recombinant FSH in the treatment of oligozoospermia

(2009) Carlo Foresta et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases

(2009) G. Corona et al.   INTERNATIONAL JOURNAL OF ANDROLOGY

Hypogonadotrophic Hypogonadism in Type 2 Diabetes, Obesity and the Metabolic Syndrome

(2008) Paresh Dandona et al.   CURRENT MOLECULAR MEDICINE

A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin

(2008) David W. Warne et al.   FERTILITY AND STERILITY

Seminal anti-Mullerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism

(2008) A.A. Sinisi et al.   HUMAN REPRODUCTION

Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice

(2008) John Falardeau et al.   JOURNAL OF CLINICAL INVESTIGATION

Male hypogonadism

(2008) Andrea M. Isidori et al.   Pituitary